FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Talwin (Pentazocine Lactate Injection, USP, CIV)
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction

Hospira, Inc. (New 04/16/2018)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
30 mg/mL; 1 mL glass ampul (NDC 00409-1941-01) 04/16/2018 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English